VLA 0.00% $1.75 viralytics limited

Ann: VLA to Present CAVATAK Clinical Data at Upcoming Conferences-VLA.AX, page-4

  1. 12,359 Posts.
    lightbulb Created with Sketch. 1105
    Hi,
    I think the results will be outstanding and hopefully management can give us holders an update on what their plans are going forward.

    I suspect we will get an announcement just after these upcoming results that will see a more substantial collaboration with Merck hopefully with some dollars involved.

    Iam happy to hold but a game plan update would be appreciated .

    Aloha.
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.